All dysexecutive, behavioural and amnestic Alzheimer’s disease patients with available CSF and/or PET data were classified as amyloid- and tau-positive, and those who underwent autopsy had Alzheimer’s disease as their primary pathological diagnosis. This evidence concerns the gene MAPT and Alzheimer disease.